chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient was red, swollen, and bruised at site of injection. Thursday, four days after the vaccination, the swelling in the left arm was still actively increasing despite frequent ibuprofen and ice application. Patient reported constant pain. The patient also had significant axillary lymph node swelling on the left side.
Information has been received from a physician concerning a female patient who on an unspecified date was vaccinated with a dose of GARDASIL (lot # was not reported). The physician reported that after receiving the vaccine the patient then experienced tachycardia which was later diagnosed as "mono". The patient sought unspecified medical attention. Additional information has been requested.
Fever (101F), bodyaches/back pains, mild sore throat, fatigue and restlessness.
Temp to 103.3, fussy, decreased appetite.  Admitted for septic workup and Ampicillin and Cefotaxime.  Developed diarrhea.  9/26/08 Reviewed hospital medical records of 8/23-8/26/2008. FINAL DX: no d/c summary available.  H&P states fever, r/o sepsis Records reveal patient experienced irritability, decreased appetite, fever starting after vaccinations.  Temp in ER 103.3.  Tx w/IV antibiotics
Sleep became a huge issue for me. I could not sleep at night, mostly from pain. I've experienced brain fog. The fatigue has been terrible during the day. My smell and taste were not compromised during the 1st vaccine but were the 2nd vaccine. I have a lot of brain fog. I don't think its attributed to my age, but I don't know. It just all ties in with this, I don't believe it is. But the pain and some injury sites I've had have flared up so bad, they've been relentless since last spring. Experienced depression over these various things. Had to go on Hydrocodone because of the pain and only getting 2-3 hours of sleep at night. I haven't been able to return to work. I went back part time or as a temp back in September and I haven't been back since November 2021. Experienced the same symptoms after the first vaccine, but 2nd vaccine symptoms were much worse. I was referred to a pain specialist by the doctor and was given more Gabapentin. Did an x-ray on my knee, and they thought it was arthritis, but I don't have arthritis in my knee according to the pain specialist. Everything has just flared up. Because of my reaction to the 2nd dose, I have not received any boosters also in guidance with my doctor.
Couldn't lift hand very high; Lump in injection site arm; 10 days of weakness; on and off chest pain for a couple days; 2-3 days after vaccine injection site arm soreness; This spontaneous case was reported by a patient and describes the occurrence of MOBILITY DECREASED (Couldn't lift hand very high), VACCINATION SITE MASS (Lump in injection site arm), ASTHENIA (10 days of weakness), CHEST PAIN (on and off chest pain for a couple days) and MYALGIA (2-3 days after vaccine injection site arm soreness) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced MOBILITY DECREASED (Couldn't lift hand very high), VACCINATION SITE MASS (Lump in injection site arm), ASTHENIA (10 days of weakness), CHEST PAIN (on and off chest pain for a couple days) and MYALGIA (2-3 days after vaccine injection site arm soreness). On 03-Apr-2021, MOBILITY DECREASED (Couldn't lift hand very high), CHEST PAIN (on and off chest pain for a couple days) and MYALGIA (2-3 days after vaccine injection site arm soreness) had resolved. On 10-Apr-2021, ASTHENIA (10 days of weakness) had resolved. At the time of the report, VACCINATION SITE MASS (Lump in injection site arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was reported.
Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen; Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) and PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen). On 16-Apr-2021, EXPIRED PRODUCT ADMINISTERED (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) had resolved. At the time of the report, PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant  medications were reported. No  treatment medications were provided.  On 15-Mar-2021, They received shipment, and since they did not know it was refrozen, they used it beyond 14-Apr-2021.  They have a sheet from the first shipment, that showed the transport conditions up to the time they had it. The earliest time on this sheet was 15-Mar-2021 at 6.45 am, and the graph started at 0.4°C at 6.45am, it has a 10-15 minutes time stamp, and states that between 6:45 and 7am it had -2°C.  Once they received the shipment, they placed it at freezer temperature, at around -20°C. After that, they removed a vial from the freezer to use it that same day, whenever they needed a vial to administer the vaccine. Date of first administration was around 17-Mar-2021, could not remember the exact date. Reporter did not know the expiration date, the states stated that by their numbers, the doses were viable up to 14-Apr-2021, the 30 days since it was thawed. Number of vials/doses impacted was 300 doses in total, 71 doses were administered to patients.
Severe numbness tingling in all extremities, numb tongue, left side of face numb, chest pain, hip Pain,
This spontaneous report as received from a pharmacist via company representative and refers to a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On an unknown date, the patient was vaccinated with ZOSTAVAX (dose, frequency and route of administration were not reported; indication provided as "vaccination"). Concomitant therapy was not reported. On an unknown date the patient experienced unknown rash on an unknown area of the body after receiving a dose of ZOSTAVAX. The outcome of the rash was unknown. Causality assessment was not reported. Additional information has been requested.
I experienced a chemical-like smell in my nose on the evening I received the vaccination (Jan.5), and on the next 2 days (Jan 6 and 7).  The smell was sporadic and diminishing over the  course of 3 days, and was no longer experienced on January 8.
Pt recvd 3 doses of Engerix-B & 19MAY91 tested pos for immunity to Hep B vax; 15JUN92 again because of a needlestick a titer was taken & pt was found to have no detectable antibodies;
sore arm; soreness; headache; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), PAIN (soreness), HEADACHE (headache), CHILLS (chills) and PYREXIA (fever) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm), PAIN (soreness), HEADACHE (headache), CHILLS (chills) and PYREXIA (fever). At the time of the report, PAIN IN EXTREMITY (sore arm), PAIN (soreness), HEADACHE (headache), CHILLS (chills) and PYREXIA (fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment medication was reported.   This case was linked to INC.-MOD-2021-074917 (E2B Linked Report). This case was linked to MOD-2021-074917 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 16-Jul-2021: Additional information received on 16-Jul-2021 with no new information; Sender's Comments: INC.-MOD-2021-074917:dose 2.
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expiration date was yesterday and four shots were accidentally given out) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041J21A) for COVID-19 vaccination. No Medical History information was reported. On 29-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 29-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (expiration date was yesterday and four shots were accidentally given out). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expiration date was yesterday and four shots were accidentally given out) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No Concomitant product use was reported. The reporter stated that the vaccine they had in stock said the expiration date was yesterday 28-Apr-2022 and four shots were accidentally given out. The date the vial was initially stored in the refrigerator was 26-Apr-2022. It was reported that the vial didn't undergo any temperature excursions. The doses administered were booster 0.25 mL doses. No treatment information was reported. Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2022: Follow up received contains no new information.
Vesicular rash 1 week following vaccination.  On 4/16/08, 5-6 vesicles on trunk and face.
Severe headache, 102.5 F fever, neck and joint pain. Fever resolved after 3-4 days, headache, neck and joint pain resolved after 4-5 days
Pt Chief complain: 42 yo AD male recieved Anthrax vaccine on 24 May 08, fifth Anthrax vaccination. 10 to 15 minutes after her recieved vaccine his right side face swelled up and the right side of the body became numb right arm and right leg became paralyzed. The pt states he had movement back in his leg on 27 May 2008 and some movement in his right arm but still cont. to have finger twitching and unable to fully exted his right arm but some improvement in strenght.The pt states he had similar reaction to anthrax vaccination after last shot one year ago and the adverse reaction lasted for about 1.5 months.
Swelling, redness and heat at the injection site on right deltoid.  Mother applied ice and gave pain reliever.
Pt was given vaccines on 8-16-2007. She then, on the same day, went to the circus and road a live Elephant. On 8-18-07 she developed Urticaria over her legs, which over the next 2 days spread over her body. Her mother called the office on 8-20-07 and we had her come in immediately. She was seen by Dr and FNP. She had Urticaria over most of her body,including her face, in which some of the previous hives were now brusies. She was treated with Zyrtec liquid and PediaPred and told to call the office if the hives continued to spread or if she had any other sx such as respiratory issues or fever.
Injection Fri March 4, 2016 at 11AM at pharmacy. Pt noticed generalized rash that afternoon starting on leg. (R) shoulder rash pruritic (L deltoid vaccine) Ulcerations noticed on tongue the next day, progressed with mod-severe ulcerations and pain in mouth at visit 3-8-16
swelling pretty much right away; hives; Initial information was received on 17-Aug-2021 regarding an unsolicited valid non-serious case from a consumer/non-healthcare professional and nurse.  This case involves an (unknown age) female patient who experienced swelling pretty much right away (swelling) and hives (urticaria) when received MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA].  The past medical treatments, vaccinations, concomitant medication and family history were not provided.  It was unknown, if the patient had any medical history, concomitant disease or risk factor.  On an unknown date, the patient received a dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (Solution for injection, lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious swelling pretty much right away (swelling) and hives (urticaria) (unknown latency) following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE.  It was reported "Nurse calling on behalf of patient is wondering if the patient can receive the Pfizer BioNTech Covid 19 vaccine after having an allergic reaction to Menactra. Component of the vaccine that she is allergic to is unknown, and hasn't reacted like this to any other vaccine. Can she receive the Pfizer BioNTech Covid 19 vaccine if she is allergic to Menactra?"  It was unknown, if the patient experienced any additional symptoms/events.  It was unknown, if there were lab data/results available.  It was not reported, if the patient received a corrective treatment for all the events.  The event outcome was unknown for both the events.  There will be no information available on the batch number for this case.
pt recv vax 5MAR96 & 3 days later pt devel a diaper rash that was raised & in some places round, not quite like a yeast infect, leather texture;
severe chills, fever, h/a, swelling, size of golf ball armpit of inj arm, local soreness shoulder to elbow rt arm, duration 3-4 days;
Dizziness; Nausea; This case was reported by a consumer via call center representative and described the occurrence of dizziness in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   In 2022, the patient received the 1st dose of Shingrix. On an unknown date, 1 day after receiving Shingrix, the patient experienced dizziness and nausea. On an unknown date, the outcome of the dizziness and nausea were recovered/resolved.   It was unknown if the reporter considered the dizziness and nausea to be related to Shingrix.     Additional Information: GSK Receipt Date: 08-AUG-2022 Reporter's Comment: The patient self-reported this case. The patient received Shingrix vaccine few days ago from reporting and next day the patient experienced dizziness and nausea. The reporter did not consent to follow up.
she has a small rash on her leg; feeling unwell; slight fever; swollen lymph nodes; terrible headache; so much tiredness / fatigue; chills; joint pain all over; muscle stiffness; been sleeping a lot; dizziness; weakness; flu like symptoms; pain at injection site; feeling warm; nauseous; This is a spontaneous report received from a contactable consumer (patient) via Pfizer sponsored program COVAX US Support. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 24Mar2021 as dose 1, single for covid-19 immunization. Patient medical history included depression and under medications (unspecified), migraine, autoimmune disorder and has compromised issues from an unknown date and unknown if ongoing. Patient had allergies [unspecified]. Concomitant medication included unspecified medication of depression. On 24Mar2021, the night after receiving the first shot of vaccine patient experienced flu like symptoms, pain at injection site, feeling warm, nauseous. Patient reported that 24 hours later on 25Mar2021, patient was feeling unwell, slight fever, has swollen lymph nodes, terrible headache, so much tiredness/fatigue, chills, joint pain all over, muscle stiffness, been sleeping a lot, dizziness, weakness for 3 days. Patient stated she has a small rash on her leg and doesn't know where it came from on an unspecified date. Patient wanted to know if that was okay for her to take Midol asking if that was a safe thing to be done after receiving the 1st dose and was concerned with the side effects and what she needs to be done prior to taking the 2nd dose. Outcome of the events flu like symptoms, pain at injection site, feeling warm, nauseous and rash on leg were unknown and the rest of the events was recovered on 28Mar2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
5 minutes after injection, patient started complaining of sever chest pressure, shortness of breath.  EKG was done and EMS was called.  Patient was transported to ED since he continues to exhibit shortness of breath and still complaining of chest pain/pressure.
Headache - all of 8/29/2013; Itching and swelling of injection site:  8/30/2013 - 9/2/13; Redness of injection side (palm sized):  8/30-9/2/13; Fatigue:  8/29/13 - 9/2/13.
Red arm next to injection spot; Warm arm  next to injection spot; It is hurting; This case was reported by a consumer via interactive digital media and described the occurrence of erythema of extremities in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   In October 2022, the patient received Shingles vaccine. In October 2022, less than a week after receiving Shingles vaccine, the patient experienced erythema of extremities, skin warm and pain in arm. On an unknown date, the outcome of the erythema of extremities, skin warm and pain in arm were not recovered/not resolved.   It was unknown if the reporter considered the erythema of extremities, skin warm and pain in arm to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 22-OCT-2022 Reporter's comment: This case was reported by the patient via interactive digital media. Reporter stated that he/she had got his/her shingles vaccine 6 days ago. His/her arm was red and warm next to injection spot and was hurting. The reporter asked should he/she needs to be worried. Additional supportive information:  Follow-up would not possible, as no contact, details were available.
Pt has a history of a CABG in 2003.  Presented with symptoms of shortness of breath, fatigue and weakness.  Pt was admitted with COVID-19 pneumonia and acute hypoxic respiratory failure.
shingles fired up this week; Not happy was sick; like flu with both vaccination; shingles fired up this week; This serious case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. In SEP-2022, an unknown time after receiving Shingles vaccine, the patient experienced shingles (Verbatim: shingles fired up this week). On an unknown date, the patient experienced vaccination failure (Verbatim: shingles fired up this week) (serious criteria GSK medically significant), sickness (Verbatim: Not happy was sick) and influenza (Verbatim: like flu with both vaccination). The outcome of the vaccination failure was unknown and the outcome of the shingles, sickness and influenza were not reported.   It was unknown if the reporter considered the vaccination failure, shingles, sickness and influenza to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles, sickness and influenza to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-Mar-2023 The patient had vaccination and booster; shingles fired up this week.  Not happy, was sick, like flu with both vaccinations. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule and laboratory confirmation were unknown at the time of reporting. The follow-up would not possible as no contact details were available.
When it started, I had a dry scratchy throat and the next day I had a low temp of 100.3. That stayed about the same for a day and a half. I tested for COVID and was positive. I was prescribed PAXLOVID. I have been fine since.
LOCAL LEFT UPPER DELTOID 4 X 3CM  ERYTHEMATOUS, mild edema, + tenderness, overall feeling of illness, achiness, low grade temp.
Engerix-B pediatric given to an adult; Engerix-B pediatric given to an adult; This non-serious case was reported by a nurse via call center representative and described the occurrence of underdose in a 20-year-old female patient who received HBV (Engerix B pediatric) (batch number FB9RH, expiry date 21-JAN-2024) for prophylaxis.   On 04-APR-2023, the patient received the 1st dose of Engerix B pediatric. On 04-APR-2023, an unknown time after receiving Engerix B pediatric, the patient experienced underdose (Verbatim: Engerix-B pediatric given to an adult) and adult use of a child product (Verbatim: Engerix-B pediatric given to an adult). The outcome of the underdose and adult use of a child product were unknown.   Additional Information: GSK receipt date: 04-APR-2023 The reporter reported that an Engerix-B pediatric dose was administered to 20 year-old patient. The reporter consented to follow up by email.  At the time of reporting, the adult patient was administered with an Engerix-B pediatric dose, which led to underdose and adult use of a child product.
sz onset APR93 to present;high pitched screaming onset APR93-OCT93; presently taking depakote multiply handicapped;physical & mental impairments;depakote AUG93;ACTH inj OCT93 & NOV93;
Patient with history of vasovagal syncope. Patient took the vaccine at 0817 and felt light headed. Patient did not lose consciousness, however felt light headed and leaned toward her mom. Patient was laid down, given ice, juice/water and snacks. Patient was observed for a little while until she felt better, then went home.
Started experiencing gradual restriction in urinary flow, first noticeable on date above.  Three days later, urinary flow was fully restricted.  Urinary flow did not return to normal until over a month later.  This is the third occurrence that this has happened after being exposed to the flu virus.  In early 2013, it occurred after contracting the flu.  In the Fall of 2013, after receiving the vaccine.  The third episode, also after receiving the vaccine on date above.